» Authors » Iria Gomez-Tourino

Iria Gomez-Tourino

Explore the profile of Iria Gomez-Tourino including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 358
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Eugster A, Lorenc A, Kotrulev M, Kamra Y, Goel M, Steinberg-Bains K, et al.
Nat Commun . 2024 Oct; 15(1):9204. PMID: 39472557
Autoimmune diseases result from autoantigen-mediated activation of adaptive immunity; intriguingly, autoantigen-specific T cells are also present in healthy donors. An assessment of dynamic changes of this autoreactive repertoire in both...
2.
Kotrulev M, Gomez-Tourino I, Cordero O
Cancers (Basel) . 2024 Jul; 16(13). PMID: 39001488
Soluble CD26 (sCD26), a glycoprotein with dipeptidyl peptidase (DPP4) enzymatic activity, can contribute to early diagnosis of colorectal cancer and advanced adenomas and has been studied, including for prognostic purposes,...
3.
Cordero O, Kotrulev M, Gomez-Tourino I
Int J Mol Sci . 2024 Jul; 25(13). PMID: 39000199
Adiponectin is a circulating hormone secreted by adipose tissue that exerts, unlike other adipokines such as leptin, anti-inflammatory, anti-atherosclerotic and other protective effects on health. Adiponectin receptor agonists are being...
4.
Cordero O, Mosquera-Ferreiro L, Gomez-Tourino I
World J Gastroenterol . 2024 Jul; 30(22):2849-2851. PMID: 38947291
In this editorial we comment on the article by Agatsuma published in the . They suggest policies for more effective colorectal screening. Screening is the main policy that has led...
5.
Betancor Y, Ferreiro-Pantin M, Anido-Herranz U, Fuentes-Losada M, Leon-Mateos L, Garcia-Acuna S, et al.
Front Immunol . 2024 Apr; 15:1374728. PMID: 38660294
In the advanced renal cell carcinoma (RCC) scenario, there are no consistent biomarkers to predict the clinical benefit patients derived from immune checkpoint blockade (ICB). Taking this into consideration, herein,...
6.
Gonzalez-Melero L, Santos-Vizcaino E, Varela-Calvino R, Gomez-Tourino I, Asumendi A, Boyano M, et al.
Drug Deliv Transl Res . 2024 Mar; 14(10):2788-2803. PMID: 38427275
Melanoma is the main cause of death among skin cancers and its incidence worldwide has been experiencing an appalling increase. However, traditional treatments lack effectiveness in advanced or metastatic patients....
7.
Prieto-Diaz R, Gonzalez-Gomez M, Fojo-Carballo H, Azuaje J, El Maatougui A, Majellaro M, et al.
J Med Chem . 2022 Dec; 66(1):890-912. PMID: 36517209
The modulation of the A adenosine receptor is a promising strategy in cancer (immuno) therapy, with AAR antagonists emerging as immune checkpoint inhibitors. Herein, we report a systematic assessment of...
8.
Cordero O, Vieitez I, Altabas I, Nuno-Nuno L, Villalba A, Novella-Navarro M, et al.
Arch Immunol Ther Exp (Warsz) . 2022 Mar; 70(1):12. PMID: 35304639
In rheumatoid arthritis (RA), the identification of biomarkers to adjust treatment intensity and to correctly diagnose the disease in early stages still constitutes a challenge and, as such, novel biomarkers...
9.
Arif S, Gomez-Tourino I, Kamra Y, Pujol-Autonell I, Hanton E, Tree T, et al.
Diabetologia . 2020 Apr; 63(6):1186-1198. PMID: 32248243
Aims/hypothesis: Antigen-specific therapy aims to modify inflammatory T cell responses in type 1 diabetes and restore immune tolerance. One strategy employs GAD65 conjugated to aluminium hydroxide (GAD-alum) to take advantage...
10.
Calvino-Sampedro C, Gomez-Tourino I, Cordero O, Reche P, Gomez-Perosanz M, Sanchez-Trincado J, et al.
FASEB J . 2019 Mar; 33(5):6390-6401. PMID: 30817223
Type 1 diabetes (T1D) results from the destruction of pancreatic β-cells by the immune system, and CD8 T lymphocytes are critical actors in this autoimmune response. Pancreatic islets are surrounded...